Infections in Pediatric Cancer Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2009 by Hadassah Medical Organization.
Recruitment status was  Not yet recruiting
Information provided by:
Hadassah Medical Organization Identifier:
First received: June 28, 2009
Last updated: June 29, 2009
Last verified: June 2009

A prospective epidemiological study conducted in pediatric hematology oncology center in Hadassah medical center. The study will include all newly diagnosed pediatric cancer patients age 0-18 years admitted with fever during chemotherapy.

In each event of febrile episode during chemotherapy, the following data will be collected using a patient data form and computerized software.

Demographic data: age, gender, ethnicity. Clinical data: Underlying disease, immunizations, prophylactic antibiotics, presence of central venous catheter, intensity of chemotherapy, duration of fever, duration and severity of neutropenia, diagnosis of present event.

Imaging data Microbiological data Outcome The statistical analysis will be performed by an epidemiologist and statistician using the SPSS 12.0 software.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Epidemiology and Etiology of Infections in Pediatric Cancer Patients: A Prospective Study

Resource links provided by NLM:

Further study details as provided by Hadassah Medical Organization:


Ages Eligible for Study:   up to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

All newly diagnosed pediatric cancer patients age 0-18 years admitted with fever during or following chemotherapy


Inclusion Criteria:

  • Pediatric cancer patients age 0-18 years admitted with fever during or following chemotherapy

Exclusion Criteria:

  • No exclusions
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00930267

Contact: Arik Tzukert, DMD 00 972 2 6776095
Contact: Hadas Lemberg, PhD 00 972 2 6777572

Sponsors and Collaborators
Hadassah Medical Organization
Principal Investigator: Dan Engelhard, MD Hadassah Medical Center
Principal Investigator: Diana Averbuch, MD Hadassah Medical Center
  More Information

No publications provided Identifier: NCT00930267     History of Changes
Other Study ID Numbers: yael12-HMO-CTIL
Study First Received: June 28, 2009
Last Updated: June 29, 2009
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Hadassah Medical Organization:
stem cell transplantation
infections in pediatric cancer patients presenting with fever during or following chemotherapy.

Additional relevant MeSH terms:
Communicable Diseases
Infection processed this record on October 08, 2015